Previous studies demonstrated that a high percentage of tumours such as breast, cervical, endometrial, colorectal, prostate cancer and malignant melanoma express RANK, and some of them also express RANKL [6,21,22,23]. This evidence concerns the gene TNFRSF11A and Familial prostate cancer.